Business Wire

Sigfox 0G Network on Track to Establishing a Standard

20.2.2019 13:00:00 EET | Business Wire | Press release

Share

2018 was marked by strong growth for Sigfox, the first global 0G network, confirming its leadership in small data collection. The French-based company has now validated its unique standard with major industries and key players trusting Sigfox as the world’s leading small data provider.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190220005403/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Raouti Chehih, Marion Moreau and Franck Siegel, members of Sigfox Exco (Photo: Sigfox)

Significant, measurable milestones have been reached by the company such as:

  • The expansion of its network to 60 countries through new Sigfox Operators joining the largest IoT ecosystem in the world. More than 500M € have been invested by Sigfox and Sigfox Operators to create this unique network.
  • The latest milestone was reached at the end of December 2018, with Poland joining the Sigfox Operators family allowing Sigfox to become the only operator offering full European coverage
  • 1 billion people are now covered by the network. This represents a huge milestone since the beginning of the company’s epic adventure, which started with the first antenna installation in France in 2011
  • Data services activity is now successfully growing with more and more significant deals secured: 6,2 million devices are connected to Sigfox network as per last year’s objective (+148%), and 13 million messages are collected every day.

Overall, the company’s total revenue has increased by 20% since 2017, bringing it to 60 million euros. Connectivity revenue has increased by almost 100%. In just 4 years, Sigfox’s revenue has increased by 400%.

  • The dynamic market has been enhanced with Sigfox’s unique value proposition based on robust technology and plug-and-play solutions. In 2018, Sigfox signed major deals with industry leading companies including Dachser, Getrak, Michelin, NEC, Netstar, PSA/IBM and Total for asset tracking, demonstrating that Sigfox is 100% a viable solution to digitalize industrial patrimony. Tier one manufacturers in the automotive and mobile industries, Alps and LiteOn also joined the Sigfox ecosystem.

Sigfox is also playing a remarkable role in the back up of connectivity services. 0G technology has been chosen and integrated into the innovative FreeBox Delta, through a strategic partnership with Free, Iliad Group led by Xavier Niel, with the use case showcased during its latest keynote in Paris, France.

Indeed, Sigfox technology is a reliable alternative service of communication for security devices. Over the last 5 years, 2.8 million Securitas alarms have been linked to the Sigfox network.

  • The adoption of Sigfox is growing tremendously with more than 200 universities, and partners as well as more than 1.200 startups developing the future with Sigfox’s simple technology. The first Hacking House is now open in San Francisco to accelerate emerging solutions across industries.
  • Sigfox technology is now being democratized with the recent opening of its specifications for devices. This major step will empower the whole ecosystem of device makers as well as academic communities to develop new solutions connecting the unconnected.

The World is not enough!

As part of its ambitious 5 year strategy referred to as “1B23”, Sigfox is naturally working towards its target of connecting 1 billion devices to its 0G network by the end of 2023.

The execution of the strategy, driven by an international Exco team and backed by its two co-founders, is structured around the following initiatives:

  • Achieving a global footprint of its 0G network by expanding in strategic countries: India, Russia, China.
  • Partnering with Eutelsat, Sigfox will test its first Satellite in H2 2019: The two companies will finetune their offer to prepare for the commercial launch of the “ELO” constellation in 2020. The key objective is to cover the entire planet under one single umbrella with simplicity and high capacity as a result of a combination of ground and satellite networks. The Sigfox ecosystem and customers will experience satellite usage without modifying their existing devices.

With its unique coverage and large quantity of connected devices, Sigfox definitely demonstrates its performance and relevance. Tier one customers around the globe acknowledge our value proposition with a high level of satisfaction. It’s no longer a dream to track assets across continents with a few dollar trackers with years of autonomy. Only a 0G network can deliver such performance. But it’s never enough, save the date for Sigfox Connect in Singapore” said Ludovic Le Moan, CEO and Co-Founder of Sigfox.

About Sigfox www.sigfox.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:
Sigfox
Antoine Mège, PR & Content Manager
antoine.mege@sigfox.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye